← Back to Clinical Trials
Recruiting NCT06786039

Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Preterm Infant
Sponsor Korea University Anam Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 1 Hour
Max Age 48 Hours
Start Date 2025-01-20
Completion 2029-12-20
Interventions
Non-invasive NAVA

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a prospective observational study investigating the impact of NIV-NAVA on short-term clinical outcomes and long-term neurodevelopment in very preterm infants.

Eligibility Criteria

Inclusion Criteria: * Preterm infants born between 27 weeks 0 days to 31 weeks 6 days of gestation * Preterm infants who require respiratory support within the first 48 hours of life Exclusion Criteria: * Preterm infants who die within the first 48 hours of life * Preterm infants who do not require any respiratory support within the first 48 hours of life. * Preterm infants with congenital anomalies affecting the lungs, heart, or other organs that could influence breathing * Infants whose parents do not consent to participate in the study

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE PRETERM INFANT TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}